Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

AVEO Pharmaceuticals presents new anti-GDF-15 MAbs

July 18, 2014

Previously identified RIP1 kinase inhibitor potentially useful for necroptosis

Jan. 24, 2014

P2X1 receptor revealed as a target in transfusion-related acute lung injury

Aug. 6, 2013

Novel autotaxin inhibitors reported by Pfizer

May 23, 2013

Model of hyperoxic injury shows adaptive changes against infection and ROS

Jan. 31, 2013

Novel vitamin E derivative suppresses oxidative stress in animal models of traumatic injury

Jan. 25, 2013

New vaccines for birch pollen allergy presented by Teknologian Tutkimuskeskus

Nov. 20, 2012

Pacific Therapeutics reports encouraging phase I results with combination treatment for fibrosis

Nov. 15, 2012

Researchers at Reata Pharmaceuticals prepare new NO production inhibitors

Oct. 16, 2012

Biotie Therapies describes novel SSAO inhibitors

Oct. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...